Dramatic decreases in brain reward function during nicotine withdrawal

被引:514
作者
Epping-Jordan, MP [1 ]
Watkins, SS [1 ]
Koob, GF [1 ]
Markou, A [1 ]
机构
[1] Scripps Res Inst, Dept Neuropharmacol, La Jolla, CA 92037 USA
关键词
D O I
10.1038/30001
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Tobacco smoking is a worldwide public health problem. In the United States alone, over 400,000 deaths and $50 billion in medical costs annually are directly attributed to smoking(1). Accumulated evidence indicates that nicotine is the component of tobacco smoke that leads to addiction(2), but the means by which nicotine produces addiction remain unclear. Nicotine is less effective as a positive reinforcer than other drugs of abuse in non-dependent animals(3). Nevertheless, nicotine-withdrawal symptoms, including depressed mood, anxiety, irritability and craving(4,5) in dependent subjects may contribute to the addictive liability of nicotine(6,7). We show here that spontaneous nicotine withdrawal in rats resulted in a significant decrease in brain reward function, as measured by elevations in brain reward thresholds, which persisted for four days. Further, systemic injections of a competitive nicotinic-receptor antagonists led to a dose-dependent increase in brain reward thresholds in chronic nicotine-treated rats. The decreased function in brain reward systems during nicotine withdrawal is comparable in magnitude and duration to that of other major drugs of abuse(9-13), and may constitute an important motivational factor that contributes to craving, relapse and continued tobacco consumption in humans(7).
引用
收藏
页码:76 / 79
页数:4
相关论文
共 30 条
  • [1] BAUCO P, 1994, J PHARMACOL EXP THER, V271, P294
  • [2] BENOWITZ NL, 1988, NEW ENGL J MED, V319, P1318
  • [3] IN-VIVO PHARMACOLOGICAL EFFECTS OF DIHYDRO-BETA-ERYTHROIDINE, A NICOTINIC ANTAGONIST, IN MICE
    DAMAJ, MI
    WELCH, SP
    MARTIN, BR
    [J]. PSYCHOPHARMACOLOGY, 1995, 117 (01) : 67 - 73
  • [4] URGES TO SMOKE DURING THE FIRST MONTH OF ABSTINENCE - RELATIONSHIP TO RELAPSE AND PREDICTORS
    DOHERTY, K
    KINNUNEN, T
    MILITELLO, FS
    GARVEY, AJ
    [J]. PSYCHOPHARMACOLOGY, 1995, 119 (02) : 171 - 178
  • [5] GELLERT VF, 1978, J PHARMACOL EXP THER, V205, P536
  • [6] Behavioral manifestations of the nicotine abstinence syndrome in the rat: Peripheral versus central mechanisms
    Hildebrand, BE
    Nomikos, GG
    Bondjers, C
    Nisell, M
    Svensson, TH
    [J]. PSYCHOPHARMACOLOGY, 1997, 129 (04) : 348 - 356
  • [7] SMOKING CESSATION AMONG SELF-QUITTERS
    HUGHES, JR
    GULLIVER, SB
    FENWICK, JW
    VALLIERE, WA
    CRUSER, K
    PEPPER, S
    SHEA, P
    SOLOMON, LJ
    FLYNN, BS
    [J]. HEALTH PSYCHOLOGY, 1992, 11 (05) : 331 - 334
  • [8] HUGHES JR, 1991, ARCH GEN PSYCHIAT, V48, P52
  • [9] EFFECTS OF NICOTINE ON THE THRESHOLD FOR REWARDING BRAIN-STIMULATION IN RATS
    HUSTONLYONS, D
    KORNETSKY, C
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1992, 41 (04) : 755 - 759
  • [10] PROSPECTIVE-STUDY OF FACTORS INFLUENCING THE DEVELOPMENT OF CRAVING ASSOCIATED WITH SMOKING CESSATION
    KILLEN, JD
    FORTMANN, SP
    NEWMAN, B
    VARADY, A
    [J]. PSYCHOPHARMACOLOGY, 1991, 105 (02) : 191 - 196